🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,157 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8961975

Monoclonal antibodies that neutralize anthrax toxins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8957192

Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8957188

Antibodies that bind GalNAc1-3Gal, pharmaceutical compositions and methods of using same

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8951793

Method of making an isolated population of FOXP3+ regulatory T cells

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8951527

Radioprotectants targeting thrombospondin-1 and CD47

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8946291

Compositions and methods for treating pigmentary conditions and melanoma

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8946398

Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8946382

Apelin peptides and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8946243

Compounds and methods for the treatment of viral infection

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8936787

Peptides promoting lipid efflux

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8937067

Activators of human pyruvate kinase

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8936792

Pseudomonas exotoxin a with reduced immunogenicity

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8933041

System for treating and preventing breast cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8927725

Thio compounds

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8927269

Avian adenoassociated virus and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8921050

Methods of diagnosing renal cell carcinoma

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8921340

Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases o

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8921323

Methods and compositions for modulating BCL-2 family polypeptides

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8921097

Methods for expression and purification of immunotoxins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8916159

Selenocysteine mediated hybrid antibody molecules

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8916596

Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhib

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8916570

A3 adenosine receptor agonists and antagonists

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8916175

Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of inf

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8912214

Use of Chk2 kinase inhibitors for cancer treatment

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted